Covered recipient · General Payments record
MARY-ANN ABRAHAM
Allopathic & Osteopathic Physicians Psychiatry & Neurology Geriatric Psychiatry
General Payments · PY2021–2023
$163.56
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.45 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $33.28 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.31 | 1 |
| Neurocrine BioSciences, Inc. | $18.66 | 1 |
| Janssen Pharmaceuticals, Inc | $18.07 | 1 |
| Alkermes, Inc. | $16.35 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.28 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $16.35 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022765425 | CMS |
| Eisai Inc. | $16.81 | 11/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023322097 | CMS |
| Eisai Inc. | $16.47 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023322099 | CMS |
| Janssen Pharmaceuticals, Inc | $18.07 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987917847 | CMS |
| Neurocrine Biosciences, Inc. | $18.66 | 07/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052362815 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.28 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014164923 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.31 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055324287 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.50 | 08/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056988477 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.